Title	Publication Date	Language	Citations
Prospective assessment of falls in Parkinson's disease	2001/11/01		543
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy	2004/03/01		419
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)	2013/11/23	English	408
From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness	2011/06/16	English	393
Impact of COVID-19 lockdown on sleep quality in university students and administration staff	2020/07/11	English	364
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)	2002/10/01		349
The window of therapeutic opportunity in multiple sclerosis	2005/07/27	English	335
The association between smoking and smell and taste impairment in the general population	2008/07/28	English	320
Episodic vertigo related to migraine (90 cases): vestibular migraine?	1999/10/25		308
“Taste Strips” – A rapid, lateralized, gustatory bedside identification test based on impregnated filter papers	2009/02/01	English	295
Posterior reversible encephalopathy syndrome	2017/01/04	English	294
Status Epilepticus Severity Score (STESS)	2008/09/03	English	290
Cyclosporine neurotoxicity: a review	1999/05/26		270
Water content and myelin water fraction in multiple sclerosis	2004/03/01		265
Friedreich ataxia: The clinical picture	2009/03/01	English	250
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy	2013/08/22	English	249
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension	2017/01/03	English	246
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms	2020/05/26	English	243
Falls in frequent neurological diseases	2004/01/01		239
Antibodies and neuronal autoimmune disorders of the CNS	2009/12/25	English	239
Management of brain metastases	2002/10/01		236
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia	2007/04/11	English	235
Psychiatric comorbidities of episodic and chronic migraine	2012/11/07	English	232
Hypermetabolism in ALS patients: an early and persistent phenomenon	2009/03/22	English	229
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases	2020/08/25	English	229
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis	2011/07/01	English	226
Copper deficiency myelopathy	2010/03/16	English	225
The natural course of non–classic Pompe’s disease; a review of 225 published cases	2005/08/01	English	224
Cervical artery dissection?clinical features, risk factors, therapy and outcome in 126 patients	2003/10/01		222
A prevalence study of primary dystonia in eight European countries	2000/10/30		220